Sightline Medical Products Preview Zenoptiq and Tozal
Dedicated Brands

Empowering Consumer Ocular Wellness with Clinically Inspired Brands

SightLine’s Dedicated Brands are built for the patient-first journey. We combine clinical-grade formulations with consumer appeal, delivering trusted products that complement in-office care. From advanced serums and therapeutics to daily eye health essentials, our brands bridge practice credibility and patient reach.

Our current portfolio includes Zenoptiq®, a pH-balanced hypochlorous acid eyelid and lash cleanser formulated to support ocular surface health and daily hygiene, and Tozal®, an AREDS 2+ based vitamin enhanced with taurine and other antioxidants to help protect macular health. Together, these products reflect our commitment to clinically inspired innovation that is both accessible and effective for patients.

Reliable, U.S.- Manufactured Products

Zenoptiq_Hdr
Gentle | Soothing | All Natural

Zenoptiq® Hypochlorous Acid is a natural cleansing agent in a non-prescription strength formula. Zenoptiq® gently cleanses eyelids, removing debris that may cause blockage of the glands. Studies have shown Hypochlorous Acid kills bacteria and may reduce inflammation giving patients relief from symptoms associated with MGD, Blepharitis and Dry Eye. Conveniently stored in a safe, shatterproof bottle, Zenoptiq® is an easy choice for daily cleansing.
Zenoptiq 3.38oz Spray Bottle

Zenoptiq®

Daily eyelid and eyelash cleanser.
Available without a prescription.

  • Gently Cleanses
  • Nontoxic, Nonirritating
  • Steroid- and Antibiotic-Free
  • Comforting and Soothing
  • Relieves Minor Eyelid and
    Eyelash Discomfort
Zenoptiq_Kill-Time-Chart
Zenoptiq_Icon_Skin-Safe

Sensitive & non-toxic

Zenoptiq® is safe for use on skin, even sensitive skin. It is non-toxic, non-irritating, and is steroid and antibiotic free.

Advanced Formulation

Zenoptiq’s advanced stabilized formulation includes Hypochlorous Acid, a gentle and drug-free cleanser.

Join as a provider partner

Reliable, U.S.- Manufactured Products

Tozal Header
Enhance the future of your ocular health

Containing ingredients proven to be beneficial to the eye, TOZAL® goes beyond the AREDS 2 formulation to help support overall ocular health.

TOZAL - Bottle New

TOZAL®

TOZAL® is different than other eye supplements!

It goes beyond AREDS 2 formulation to support your ocular health with comprehensive ingredients including Taurine, Omega-3, Zinc, Antioxidants, Lutein/Zeaxanthin, Vitamins A, B6, D3, and Folic Acid.

  • Re-esterified triglyceride omega-3
  • Study shows improved or stabilized vision in 3 out of 4 people who took TozalΔ*
  • Actilease® beadlet technology for better dissolutionΔ
AREDS2_vs_Tozal_chart_2025

TOZAL’s name says it all:

TAURINE

Taurine is an amino acid that protects the photoreceptor cells of the retina allowing the optic nerve to process light. 1

OMEGA-3
  • Omega-3 fatty acid is an essential component of cell membranes in the retina and optic nerve. 2
  • The triglyceride form may have an increased absorbability and is comparable to the naturally occurring form found in fish. 3
  • Some studies show that Omega-3 may reduce the instances of age-related macular degeneration (AMD) by up to 30%.
ZINC Picolinate
  • While the AREDS 2 formulation includes 80 mg of Zinc, the study actually found that 25 mg is just as effective in a supplement targeting age-related eye concerns.*
  • Zinc picolinate is absorbed to a higher degree than other forms of zinc.4
ANTIOXIDANTS (Vitamins A, C, D3 & E)
  • Antioxidants fight free radicals to help prevent cellular damage.5,7
  • Vitamin A (as Retinyl Palmitate)- Helps process night vision and acts in combination with other antioxidants, such as vitamin C and vitamin E, which may help decrease the progression of AMD.8
  • B-Complex (B6 & Folic Acid)- B-Complex vitamins may assist in the reduction of homocysteine levels.9
  • Vitamin D3- Adequate vitamin D levels may prevent AMD in people with a high genetic risk.10
LUTEIN/Zeaxanthin

These carotenoids are found in the retina and may help protect against high-energy blue and ultraviolet light.6

TOZAL_FDA_Statement

1. Huxtable, R. J. (1992 , January). Physiological actions of taurine. Physiological Reviews, 72(1), 101-163.
2. SanGiovanni JP, et al. (2005, January). The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res., 24(1), 87-138.
3. Alexander, Larry J. (2011, January). Is There a Difference Between Re-esterified Triglyceride and Ethyl Ester Fish Oil? Advanced Ocular Care, 20-21.
4. Barrie, S., Wright, J., Pizzorno, J., Kutter, E., & Barron, P. (1987). Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans. Agents Actions, 21(1-2), 223–228.
5. Lobo V, Patil A, Phatak A, Chandra N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Phcog Rev, 4, 118-26.
6. The Age-Related Eye Disease Study 2 (AREDS2) Research Group*. (2013). Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA., 309(19), 2005-2015.
7. For the Public: What the AREDS Means For You. (2013). Retrieved from National Eye Institute.
8. Heiting, G. (2017). Vitamin A And Beta-Carotene: Eye Benefits. Retrieved from All About Vision: allaboutvision.com
9. Christen, W. G., Glynn, R. J., Chew, E. Y., Albert, C. M., & Manson, J. E. (2009). Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-related Macular Degeneration in a Randomized Trial of Women. Archives of Internal Medicine, 169(4), 335–341.
10. Millen AE, Meyers KJ, Liu Z, et al. (2015). Association Between Vitamin D Status and Age-Related Macular Degeneration by Genetic Risk. JAMA Ophthalmol, 133(10), 1171-1179.
11. Actilease®. (2015). Retrieved from DSM.
12. Richer S, Newman S. (n.d.). Diet & Nutrition. Retrieved from American Optometric Association.
13. Kant, AK (2003). Reported Consumption of Low-Nutrient-Density Foods by American Children and Adolescents Nutritional and Health Correlates, NHANES III, 1988 to 1994. Arch Pediatr Adolesc Med, 157(8), 789-796.

Join as a provider partner